Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Saxenda
Pharma
Novo weight-loss drugs pose risk of stomach problems: study
People who use Novo's weight-loss drugs are taking on a small risk of severe stomach problems, according to a new study. But the risk is small.
Kevin Dunleavy
Oct 6, 2023 12:55pm
Increased demand squeezes supplies of Eli Lilly's Mounjaro—again
Jul 26, 2023 9:57am
Lawmakers, Big Pharmas push for Medicare obesity drug coverage
Jul 20, 2023 3:01pm
Weight-loss drug shortage expands to Novo's Saxenda
Jul 19, 2023 11:24am
EMA will monitor suicide risk in Novo Nordisk's GLP-1 products
Jul 10, 2023 11:11am
Bloomberg predicts obesity drug sales hitting $44B by 2030
May 31, 2023 9:10am
